Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

OBJECTIVE: The primary objective was to assess the effect of MVC intensification on latently infected CD4(+) T cells in chronically HIV-1-infected patients receiving antiretroviral therapy. METHODS: We performed an open-label pilot phase II clinical trial involving chronically HIV-1-infected patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Carolina, Díaz, Laura, Vallejo, Alejandro, Hernández-Novoa, Beatriz, Abad, María, Madrid, Nadia, Dahl, Viktor, Rubio, Rafael, Moreno, Ana M., Dronda, Fernando, Casado, José Luis, Navas, Enrique, Pérez-Elías, María Jesús, Zamora, Javier, Palmer, Sarah, Muñoz, Eduardo, Muñoz-Fernández, María Ángeles, Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234247/
https://www.ncbi.nlm.nih.gov/pubmed/22174752
http://dx.doi.org/10.1371/journal.pone.0027864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234247/
https://www.ncbi.nlm.nih.gov/pubmed/22174752
http://dx.doi.org/10.1371/journal.pone.0027864

Ejemplares similares